Skip to main content Accessibility help
×
Home

Clinical impact of an antimicrobial stewardship program on high-risk pediatric patients

  • Jennifer L. Goldman (a1), Jason G. Newland (a2), Michael Price (a3), Diana Yu (a4) and Brian R. Lee (a1)...

Abstract

Objective:

To evaluate the clinical impact of an antimicrobial stewardship program (ASP) on high-risk pediatric patients.

Design:

Retrospective cohort study.

Setting:

Free-standing pediatric hospital.

Patients:

This study included patients who received an ASP review between March 3, 2008, and March 2, 2017, and were considered high-risk, including patients receiving care by the neonatal intensive care (NICU), hematology/oncology (H/O), or pediatric intensive care (PICU) medical teams.

Methods:

The ASP recommendations included stopping antibiotics; modifying antibiotic type, dose, or duration; or obtaining an infectious diseases consultation. The outcomes evaluated in all high-risk patients with ASP recommendations were (1) hospital-acquired Clostridium difficile infection, (2) mortality, and (3) 30-day readmission. Subanalyses were conducted to evaluate hospital length of stay (LOS) and tracheitis treatment failure. Multivariable generalized linear models were performed to examine the relationship between ASP recommendations and each outcome after adjusting for clinical service and indication for treatment.

Results:

The ASP made 2,088 recommendations, and 50% of these recommendations were to stop antibiotics. Recommendation agreement occurred in 70% of these cases. Agreement with an ASP recommendation was not associated with higher odds of mortality or hospital readmission. Patients with a single ASP review and agreed upon recommendation had a shorter median LOS (10.2 days vs 13.2 days; P < .05). The ASP recommendations were not associated with high rates of tracheitis treatment failure.

Conclusions:

ASP recommendations do not result in worse clinical outcomes among high-risk pediatric patients. Most ASP recommendations are to stop or to narrow antimicrobial therapy. Further work is needed to enhance stewardship efforts in high-risk pediatric patients.

Copyright

Corresponding author

Author for correspondence: Jennifer Goldman, E-mail: jlgoldman@cmh.edu

Footnotes

Hide All

PREVIOUS PRESENTATION: The preliminary results of this study were presented in poster format at IDWeek 2018, October 4, 2018, in San Francisco, California.

Footnotes

References

Hide All
1.Barlam, TF, Cosgrove, SE, Abbo, LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:e51e77.
2.Suwantarat, N, Logan, LK, Carroll, KC, et al. The prevalence and molecular epidemiology of multidrug-resistant Enterobacteriaceae colonization in a pediatric intensive care unit. Infect Control Hosp Epidemiol 2016;37:535543.
3.Trubiano, JA, Worth, LJ, Thursky, KA, Slavin, MA. The prevention and management of infections due to multidrug resistant organisms in haematology patients. Br J Clin Pharmacol 2015;79:195207.
4.Tsai, MH, Chu, SM, Hsu, JF, et al. Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics 2014;133:e322e329.
5.Ting, JY, Paquette, V, Ng, K, et al. Reduction of inappropriate antimicrobial prescriptions in a tertiary neonatal intensive care unit after antimicrobial stewardship care bundle implementation. Pediatr Infect Dis J 2019;38:5459.
6.Lindsay, PJ, Rohailla, S, Taggart, LR, et al. Antimicrobial stewardship and intensive care unit mortality: a systematic review. Clin Infect Dis 2019;68:748756.
7.Robilotti, E, Holubar, M, Seo, SK, Deresinski, S. Feasibility and applicability of antimicrobial stewardship in immunocompromised patients. Curr Opin Infect Dis 2017;30:346353.
8.McPherson, C, Lee, BR, Terrill, C, et al. Characteristics of pediatric antimicrobial stewardship programs: current status of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) collaborative. Antibiotics (Basel) 2018;7.
9.Smith, MJ, Gerber, JS, Hersh, AL. Inpatient antimicrobial stewardship in pediatrics: a systematic review. J Pediatr Infect Dis Soc 2015;4:e127e135.10.1093/jpids/piu141
10.Newland, JG, Gerber, JS, Weissman, SJ, et al. Prevalence and characteristics of antimicrobial stewardship programs at freestanding children’s hospitals in the United States. Infect Control Hosp Epidemiol 2014;35:265271.
11.Goldman, JL, Lee, BR, Hersh, AL, et al. Clinical diagnoses and antimicrobials predictive of pediatric antimicrobial stewardship recommendations: a program evaluation. Infect Control Hosp Epidemiol 2015;36:673680.
12.Newland, JG SL, De Lurgio, SA, Hedican, E, et al. Impact of a prospective-audit-with-feedback antimicrobial stewardship program at a children’s hospital. J Pediatr Infect Dis 2012;1:179186.
13.Lee, BR, Goldman, JL, Yu, D, et al. Clinical impact of an antibiotic stewardship program at a children’s hospital. Infect Dis Ther 2017;6:103113.10.1007/s40121-016-0139-5
14.McCulloh, RJ, Queen, MA, Lee, B, et al. Clinical impact of an antimicrobial stewardship program on pediatric hospitalist practice, a 5-year retrospective analysis. Hosp Pediatr 2015;5:520527.
15.Gill, DP, Zou, GY, Jones, GR, Speechley, M. Comparison of regression models for the analysis of fall risk factors in older veterans. Ann Epidemiol 2009;19:523530.10.1016/j.annepidem.2009.03.012
16.Kelly, PJ, Lim, LL. Survival analysis for recurrent event data: an application to childhood infectious diseases. Stat Med 2000;19:1333.10.1002/(SICI)1097-0258(20000115)19:1<13::AID-SIM279>3.0.CO;2-5
17.Kennedy, BS, Kasl, SV, Vaccarino, V. Repeated hospitalizations and self-rated health among the elderly: a multivariate failure time analysis. Am J Epidemiol 2001;153:232241.
18.Timsit, JF, Bassetti, M, Cremer, O, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intens Care Med 2019;45:172189.
19.Wolf, J, Sun, Y, Tang, L, et al. Antimicrobial stewardship barriers and goals in pediatric oncology and bone marrow transplantation: a survey of antimicrobial stewardship practitioners. Infect Control Hosp Epidemiol 2016;37:343347.
20.Abbo, LM, Ariza-Heredia, EJ. Antimicrobial stewardship in immunocompromised hosts. Infect Dis Clin N Am 2014;28:263279.
21.Kim, J, Shaklee, JF, Smathers, S, et al. Risk factors and outcomes associated with severe clostridium difficile infection in children. Pediatr Infect Dis J 2012;31:134138.
22.Logan, LK, Gandra, S, Mandal, S, et al. Multidrug- and carbapenem-resistant Pseudomonas aeruginosa in children, United States, 1999–2012. J Pediatr Infect Dis Soc 2017;6:352359.
23.Aizawa, Y, Suwa, J, Higuchi, H, et al. Antimicrobial stewardship program in a pediatric intensive care unit. J Pediatric Infect Dis Soc 2018;7:e156e159.
24.Tamma, PD, Turnbull, AE, Milstone, AM, Lehmann, CU, Sydnor, ER, Cosgrove, SE. Ventilator-associated tracheitis in children: does antibiotic duration matter? Clin Infect Dis 2011;52:13241331.
25.Lawrence, KL, Kollef, MH. Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Resp Crit Care Med 2009;179:434438.10.1164/rccm.200809-1394CP
26.Patel, SJ, Saiman, L, Duchon, JM, Evans, D, Ferng, YH, Larson, E. Development of an antimicrobial stewardship intervention using a model of actionable feedback. Interdiscip Perspect Infect Dis 2012;2012:150367.
27.Cantey, JB, Patel, SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin N Am 2014;28:247261.
28.Dallas, J, Skrupky, L, Abebe, N, Boyle, WA 3d, Kollef, MH. Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population. Chest 2011;139:513518.10.1378/chest.10-1336

Clinical impact of an antimicrobial stewardship program on high-risk pediatric patients

  • Jennifer L. Goldman (a1), Jason G. Newland (a2), Michael Price (a3), Diana Yu (a4) and Brian R. Lee (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed